Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018 (2018), Article ID 5216383, 11 pages
https://doi.org/10.1155/2018/5216383
Research Article

Edaravone Improves Septic Cardiac Function by Inducing an HIF-1α/HO-1 Pathway

1Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China
2Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China

Correspondence should be addressed to Feng Xiao; nc.ude.usc@uscgnefoaix

Received 28 September 2017; Revised 20 December 2017; Accepted 6 February 2018; Published 22 March 2018

Academic Editor: Raquel Rodrigues-Díez

Copyright © 2018 Chao He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Annane, E. Bellissant, and J. M. Cavaillon, “Septic shock,” The Lancet, vol. 365, no. 9453, pp. 63–78, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. R. C. Bone, R. A. Balk, F. B. Cerra et al., “Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine,” Chest, vol. 101, no. 6, pp. 1644–1655, 1992. View at Publisher · View at Google Scholar · View at Scopus
  3. D. C. Angus and T. van der Poll, “Severe sepsis and septic shock,” The New England Journal of Medicine, vol. 369, no. 9, pp. 840–851, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Christaki and S. M. Opal, “Is the mortality rate for septic shock really decreasing?” Current Opinion in Critical Care, vol. 14, no. 5, pp. 580–586, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. D. B. Hoover, T. R. Ozment, R. Wondergem, C. Li, and D. L. Williams, “Impaired heart rate regulation and depression of cardiac chronotropic and dromotropic function in polymicrobial sepsis,” Shock, vol. 43, no. 2, pp. 185–191, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Thangamalai, K. Kandasamy, S. V. Sukumarn et al., “Atorvastatin prevents sepsis-induced downregulation of myocardial β1-adrenoceptors and decreased cAMP response in mice,” Shock, vol. 41, no. 5, pp. 406–412, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Lv and H. Wang, “Pathophysiology of sepsis-induced myocardial dysfunction,” Military Medical Research, vol. 3, no. 1, p. 30, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Rudiger and M. Singer, “Mechanisms of sepsis-induced cardiac dysfunction,” Critical Care Medicine, vol. 35, no. 6, pp. 1599–1608, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Furian, C. Aguiar, K. Prado et al., “Ventricular dysfunction and dilation in severe sepsis and septic shock: relation to endothelial function and mortality,” Journal of Critical Care, vol. 27, no. 3, pp. 319.e9–319.e15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. P. Sánchez-Villamil, V. D’Annunzio, P. Finocchietto et al., “Cardiac-specific overexpression of thioredoxin 1 attenuates mitochondrial and myocardial dysfunction in septic mice,” The International Journal of Biochemistry & Cell Biology, vol. 81, Part B, pp. 323–334, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Ritter, M. Andrades, M. L. C. Frota Junior et al., “Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation,” Intensive Care Medicine, vol. 29, no. 10, pp. 1782–1789, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. D. S. Wheeler, “Oxidative stress in critically ill children with sepsis,” The Open Inflammation Journal, vol. 4, no. 1, pp. 74–81, 2011. View at Publisher · View at Google Scholar
  13. L. Ji, Y. Liu, Y. Zhang et al., “The antioxidant edaravone prevents cardiac dysfunction by suppressing oxidative stress in type 1 diabetic rats and in high-glucose-induced injured H9c2 cardiomyoblasts,” Canadian Journal of Physiology and Pharmacology, vol. 94, no. 9, pp. 996–1006, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Kikuchi, S. Tancharoen, N. Takeshige et al., “The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease,” International Journal of Molecular Sciences, vol. 14, no. 12, pp. 13909–13930, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Zhang, W. Li, L. Li et al., “Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury,” Neuroscience, vol. 201, pp. 297–306, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Yamaguchi, M. H. Hussein, G. A.-H. Daoud et al., “Edaravone, a hydroxyl radical scavenger, ameliorates the severity of pulmonary hypertension in a porcine model of neonatal sepsis,” The Tohoku Journal of Experimental Medicine, vol. 223, no. 4, pp. 235–241, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Kono, M. Asakawa, H. Fujii et al., “Edaravone, a novel free radical scavenger, prevents liver injury and mortality in rats administered endotoxin,” The Journal of Pharmacology and Experimental Therapeutics, vol. 307, no. 1, pp. 74–82, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Liu, Y. Song, M. Zhao, Z. Yi, and Q. Zeng, “Protective effects of edaravone, a free radical scavenger, on lipopolysaccharide-induced acute kidney injury in a rat model of sepsis,” International Urology and Nephrology, vol. 47, no. 10, pp. 1745–1752, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. R. V. Shohet and J. A. Garcia, “Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia,” Journal of Molecular Medicine, vol. 85, no. 12, pp. 1309–1315, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Ockaili, R. Natarajan, F. Salloum et al., “HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 289, no. 2, pp. H542–H548, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. L. E. Otterbein and A. M. K. Choi, “Heme oxygenase: colors of defense against cellular stress,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 279, no. 6, pp. L1029–L1037, 2000. View at Publisher · View at Google Scholar
  22. N. Nakajima, S. Watanabe, T. Kiyoi, A. Tanaka, K. Suemaru, and H. Araki, “Evaluation of edaravone against radiation-induced oral mucositis in mice,” Journal of Pharmacological Sciences, vol. 127, no. 3, pp. 339–343, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Peng, J. Xu, W. Ruan, S. Li, and F. Xiao, “PPAR-γ activation prevents septic cardiac dysfunction via inhibition of apoptosis and necroptosis,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 8326749, 11 pages, 2017. View at Publisher · View at Google Scholar
  24. J. D. Hunter and M. Doddi, “Sepsis and the heart,” British Journal of Anaesthesia, vol. 104, no. 1, pp. 3–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Ishikawa, H. Yoshida, N. Metoki et al., “Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia,” Neuroscience Research, vol. 59, no. 4, pp. 406–412, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. R. S. Hotchkiss and D. W. Nicholson, “Apoptosis and caspases regulate death and inflammation in sepsis,” Nature Reviews Immunology, vol. 6, no. 11, pp. 813–822, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. B. A. Potz, F. W. Sellke, and M. Ruhul Abid, “Endothelial ROS and impaired myocardial oxygen consumption in sepsis-induced cardiac dysfunction,” Journal of Intensive and Critical Care, vol. 02, no. 01, 2016. View at Publisher · View at Google Scholar
  28. C. Chelazzi, G. Villa, and A. R. De Gaudio, “Cardiorenal syndromes and sepsis,” International Journal of Nephrology, vol. 2011, Article ID 652967, 8 pages, 2011. View at Publisher · View at Google Scholar
  29. J. Chen, J. Lai, L. Yang et al., “Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1,” British Journal of Pharmacology, vol. 173, no. 3, pp. 545–561, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. H. M. Chen, S. F. Liou, J. H. Hsu et al., “Baicalein inhibits HMGB1 release and MMP-2/-9 expression in lipopolysaccharide-induced cardiac hypertrophy,” The American Journal of Chinese Medicine, vol. 42, no. 4, pp. 785–797, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Lei, P. Zhang, W. Li et al., “Pre- and posttreatment with edaravone protects CA1 hippocampus and enhances neurogenesis in the subgranular zone of dentate gyrus after transient global cerebral ischemia in rats,” ASN Neuro, vol. 6, no. 6, article 175909141455841, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Bonello, C. Zahringer, R. S. BelAiba et al., “Reactive oxygen species activate the HIF-1α promoter via a functional NFκB site,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 4, pp. 755–761, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Pouyssegur and F. Mechta-Grigoriou, “Redox regulation of the hypoxia-inducible factor,” Biological Chemistry, vol. 387, no. 10-11, pp. 1337–1346, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Sanjuan-Pla, A. M. Cervera, N. Apostolova et al., “A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-1α,” FEBS Letters, vol. 579, no. 12, pp. 2669–2674, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Gorlach and T. Kietzmann, “Superoxide and derived reactive oxygen species in the regulation of hypoxia-inducible factors,” Methods in Enzymology, vol. 435, pp. 421–446, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Dawn and R. Bolli, “HO-1 induction by HIF-1: a new mechanism for delayed cardioprotection?” American Journal of Physiology-Heart and Circulatory Physiology, vol. 289, no. 2, pp. H522–H524, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Turkseven, A. Kruger, C. J. Mingone et al., “Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 289, no. 2, pp. H701–H707, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. S. F. Yet, R. Tian, M. D. Layne et al., “Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice,” Circulation Research, vol. 89, no. 2, pp. 168–173, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Li, P. Sonveaux, Z. N. Rabbani et al., “Regulation of HIF-1α stability through S-nitrosylation,” Molecular Cell, vol. 26, no. 1, pp. 63–74, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Pathak and P. R. Mayeux, “In vitro model of sepsis-induced renal epithelial reactive nitrogen species generation,” Toxicological Sciences, vol. 115, no. 2, pp. 475–481, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Kikuchi, S. Tancharoen, T. Ito et al., “Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1/RAGE axis in prevention and acute treatment of stroke,” International Journal of Molecular Sciences, vol. 14, no. 12, pp. 18899–18924, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Liu, T. Yang, R. Na et al., “The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients,” International Urology and Nephrology, vol. 47, no. 6, pp. 951–958, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. G. F. Elbaradey, N. S. Elshmaa, and H. Hodeib, “Role of edaravone in management of septic peritonitis,” Journal of Anaesthesiology Clinical Pharmacology, vol. 32, no. 4, pp. 465–469, 2016. View at Publisher · View at Google Scholar · View at Scopus